These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38020291)
1. Metabolic coupling in phyllodes tumor of the breast and its association with tumor progression. Kim NI; Park MH; Kweon SS; Lee JS Oncol Lett; 2023 Dec; 26(6):545. PubMed ID: 38020291 [TBL] [Abstract][Full Text] [Related]
2. Expression of Cav-1, MCT1, and MCT4 in Ductal Carcinoma In Situ of the Breast and Their Associations With Clinicopathologic Features. Kim NI; Park MH; Lee JS Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):204-212. PubMed ID: 36867736 [TBL] [Abstract][Full Text] [Related]
3. Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma. Martins D; Beça FF; Sousa B; Baltazar F; Paredes J; Schmitt F Cell Cycle; 2013 Aug; 12(16):2684-90. PubMed ID: 23907124 [TBL] [Abstract][Full Text] [Related]
4. Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression. Sanità P; Capulli M; Teti A; Galatioto GP; Vicentini C; Chiarugi P; Bologna M; Angelucci A BMC Cancer; 2014 Mar; 14():154. PubMed ID: 24597899 [TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function. Martinez-Outschoorn U; Sotgia F; Lisanti MP Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293 [TBL] [Abstract][Full Text] [Related]
6. The expression of metabolism-related proteins in phyllodes tumors. Kwon JE; Jung WH; Koo JS Tumour Biol; 2013 Feb; 34(1):115-24. PubMed ID: 22986897 [TBL] [Abstract][Full Text] [Related]
7. Organized metabolic crime in prostate cancer: The coexpression of MCT1 in tumor and MCT4 in stroma is an independent prognosticator for biochemical failure. Andersen S; Solstad Ø; Moi L; Donnem T; Eilertsen M; Nordby Y; Ness N; Richardsen E; Busund LT; Bremnes RM Urol Oncol; 2015 Aug; 33(8):338.e9-17. PubMed ID: 26066969 [TBL] [Abstract][Full Text] [Related]
8. Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors. Cha YJ; Koo JS PLoS One; 2020; 15(8):e0238466. PubMed ID: 32857809 [TBL] [Abstract][Full Text] [Related]
9. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer. Curry JM; Tuluc M; Whitaker-Menezes D; Ames JA; Anantharaman A; Butera A; Leiby B; Cognetti DM; Sotgia F; Lisanti MP; Martinez-Outschoorn UE Cell Cycle; 2013 May; 12(9):1371-84. PubMed ID: 23574725 [TBL] [Abstract][Full Text] [Related]
10. Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine Tumors. Hiltunen N; Rintala J; Väyrynen JP; Böhm J; Karttunen TJ; Huhta H; Helminen O Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626155 [TBL] [Abstract][Full Text] [Related]
11. Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer. Pértega-Gomes N; Vizcaíno JR; Miranda-Gonçalves V; Pinheiro C; Silva J; Pereira H; Monteiro P; Henrique RM; Reis RM; Lopes C; Baltazar F BMC Cancer; 2011 Jul; 11():312. PubMed ID: 21787388 [TBL] [Abstract][Full Text] [Related]
12. Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression. Chen H; Wang L; Beretov J; Hao J; Xiao W; Li Y Clin Exp Metastasis; 2010 Dec; 27(8):557-69. PubMed ID: 20658178 [TBL] [Abstract][Full Text] [Related]
13. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses. Kim Y; Choi JW; Lee JH; Kim YS Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395 [TBL] [Abstract][Full Text] [Related]
14. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression. Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation and prognostic value of monocarboxylate transporter 1 (MCT1) and 4 (MCT4) in T-cell non-Hodgkin lymphoma. Zhao H; Chen Y; Liao YP; Chen HM; Yang QH; Xiao Y; Luo J; Chen ZZ; Yi L; Hu GY Clin Exp Med; 2023 Feb; 23(1):55-64. PubMed ID: 35239073 [TBL] [Abstract][Full Text] [Related]
16. Coexpression of MCT1 and MCT4 in ALK-positive Anaplastic Large Cell Lymphoma: Diagnostic and Therapeutic Implications. Choi JW; Lee Y; Kim H; Cho HY; Min SK; Kim YS Am J Surg Pathol; 2022 Feb; 46(2):241-248. PubMed ID: 34619707 [TBL] [Abstract][Full Text] [Related]
17. Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis. Cao YW; Liu Y; Dong Z; Guo L; Kang EH; Wang YH; Zhang W; Niu HT Urol Oncol; 2018 Jun; 36(6):311.e15-311.e25. PubMed ID: 29657088 [TBL] [Abstract][Full Text] [Related]
18. Expression of cancer stem cell markers in breast phyllodes tumor. Kim SI; Koo JS Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396 [TBL] [Abstract][Full Text] [Related]
19. Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells. Diehl K; Dinges LA; Helm O; Ammar N; Plundrich D; Arlt A; Röcken C; Sebens S; Schäfer H Oncogene; 2018 Jan; 37(1):39-51. PubMed ID: 28846107 [TBL] [Abstract][Full Text] [Related]
20. Metformin Effects on Metabolic Coupling and Tumor Growth in Oral Cavity Squamous Cell Carcinoma Coinjection Xenografts. Tassone P; Domingo-Vidal M; Whitaker-Menezes D; Lin Z; Roche M; Tuluc M; Martinez-Outschoorn U; Curry J Otolaryngol Head Neck Surg; 2018 May; 158(5):867-877. PubMed ID: 29232177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]